Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

2.5K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor microenvironment-driven natural killer cell diversity: mechanisms and therapeutic opportunities.

Cancer biology & medicine·2026
Same author

SLC46A1 deficiency-mediated folate restriction suppresses colorectal cancer progression through epigenetic-transcriptional reprogramming.

Cell death & disease·2026
Same author

Gut microecology empowers cancer immunotherapy: commensal microbiota-mediated mechanisms and translational prospects of PD-1/PD-L1 therapy.

Cancer biology & medicine·2026
Same author

Extracellular Vesicle-Packaged miR-99a Reprograms Fibroblasts to Create an Inflammatory Niche That Drives Colorectal Cancer Metastasis.

Cancer research·2025
Same author

Interaction of PHGDH with IGF2BP1 facilitates m6A-dependent stabilization of TCF7L2 mRNA to confer multidrug resistance in gastric cancer.

Oncogene·2025
Same author

E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression.

Gut·2025

Related Experiment Video

Updated: Oct 12, 2025

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

9.7K

miR-125b Promotes Colorectal Cancer Migration and Invasion by Dual-Targeting CFTR and CGN.

Xiaohui Zhang1, Tingyu Li2, Ya-Nan Han1,3

  • 1State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China.

Cancers
|November 27, 2021
PubMed
Summary

MicroRNA-125b promotes colorectal cancer metastasis by targeting CFTR and CGN. This study reveals a novel mechanism linking miR-125b to cancer progression and potential therapeutic strategies.

Keywords:
colorectal cancerinvasionmetastasismiRNAmigration

More Related Videos

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.2K
Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
06:19

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Published on: July 18, 2017

10.3K

Related Experiment Videos

Last Updated: Oct 12, 2025

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

9.7K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.2K
Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
06:19

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Published on: July 18, 2017

10.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Metastasis significantly worsens colorectal cancer (CRC) prognosis, with underlying mechanisms incompletely understood.
  • Previous research identified miR-125b's role in cetuximab resistance in CRC.
  • Understanding novel pathways driving CRC metastasis is crucial for improved patient outcomes.

Purpose of the Study:

  • To elucidate the novel mechanism by which miR-125b promotes metastasis in colorectal cancer.
  • To identify the direct molecular targets of miR-125b involved in CRC progression.
  • To investigate miR-125b's role in epithelial-mesenchymal transition (EMT) and associated pathways.

Main Methods:

  • Quantitative real-time PCR to assess miR-125b expression.
  • Cell migration and invasion assays (in vitro).
  • RNA-sequencing (RNA-seq) and dual-luciferase reporter assays to identify gene targets.
  • In vivo metastasis models.
  • Western blotting to analyze protein expression and pathway activation.

Main Results:

  • miR-125b expression was significantly upregulated in CRC tumors and metastatic tissues.
  • Overexpression of miR-125b enhanced CRC cell migration and invasion; knockdown reduced these.
  • CFTR and CGN were identified as direct targets of miR-125b, inhibiting metastasis.
  • miR-125b promoted EMT, uPA secretion via CFTR targeting, and RhoA/ROCK pathway activation via CGN targeting.

Conclusions:

  • miR-125b plays a critical role in enhancing colorectal cancer metastasis through targeting CFTR and CGN.
  • miR-125b facilitates EMT and activates key signaling pathways (RhoA/ROCK) driving cancer spread.
  • miR-125b represents a promising biomarker for CRC diagnosis and a potential therapeutic target.